Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Lincoln Electric Q1 Profit Rises - Quick Facts

RELATED NEWS
Trade LECO now with 

Lincoln Electric Holdings Inc.(LECO: Quote) reported that net income for the first quarter 2012 was $64.2 million, or $0.76 per share, up from $46.9 million, or $0.55 per share, in the first quarter 2011. Adjusted net income for 2012 increased to $64.2 million, or $0.76 per share, from $42.3 million, or $0.50 per share, in 2011

Sales were $727.1 million in the first quarter 2012 versus $599.2 million in the comparable 2011 period, an increase of 21.4%.

Analysts polled by Thomson Reuters expected the company to report earnings of $0.66 per share on revenues of $702.25 million for the quarter. Analysts' estimates typically exclude special items.

Click here to receive FREE breaking news email alerts for Lincoln Electric and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
After moving modestly higher in morning trading, stocks showed a substantial move to the downside over the course of the trading day on Wednesday. The major averages pulled back well off their highs for the session, sliding firmly into negative territory. Ebola "czar" Ron Kain is scheduled to meet with President Barack Obama on Wednesday as he begins his efforts to coordinate the government's response to the deadly disease. Klain, who previously served as chief of staff to Vice President Joe Biden and then-Vice President Al Gore, was named as Ebola Response Coordinator last Friday. Potentially complicating the outlook for control of the Senate, the results of a SurveyUSA poll conducted for WXIA-TV in Atlanta suggest that the Georgia Senate race between Republican David Perdue and Democrat Michelle Nunn could be headed for a runoff.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.